Skip to content

Nurix Therapeutics, Inc. NRIX Book value per share

Book value per share at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$15.79+60.9%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$5.23+57.5%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.26+6.2%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$7.43-22.1%
Nuvation Bio logo
Nuvation BioNUVB
$0.85-31.7%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$2.35-257%

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$1.95B+40.1%
Enterprise value$1.94B+45.1%
P/S27.2×+2.5×

Profitability

See full
Operating margin-439.3%+35.3pp
Net margin-411.4%+52.7pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Calculated from Nurix Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s book value per share?
Nurix Therapeutics, Inc. (NRIX) reported book value per share of $4.37 in Q4 2025.
How has Nurix Therapeutics, Inc.'s book value per share changed year-over-year?
Nurix Therapeutics, Inc.'s book value per share decreased by 24.1% year-over-year, from $5.76 to $4.37.
What is the long-term trend for Nurix Therapeutics, Inc.'s book value per share?
Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s book value per share has grown at a -3.7% compound annual growth rate (CAGR), from $7.50 to $6.22.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.